Acerus to Report First Quarter 2017 Financial Results and Host Investor Call

TORONTO--()--Acerus Pharmaceuticals Corporation (TSX:ASP) will announce its first quarter 2017 financial and operating results on Friday May 12, 2017 after the market closes. The company will host a conference call on Monday, May 15, 2017 at 8:30 a.m. Eastern Time.

To access the call live, please dial 416-340-2216 or 1-866-225-2055. Listeners are encouraged to dial in 10 minutes before the call begins to avoid delays. A replay of the conference call will be available until 11:59 p.m. Eastern Time on Monday, May 22, 2017 by dialing 905-694-9451 or 1-800-408-3053, using access code: 7380968#.

About Acerus

Acerus Pharmaceuticals Corporation is a fully-integrated, Canadian specialty pharmaceutical company engaged in the development, manufacture, marketing and distribution of innovative, branded products in Men’s and Women’s Health. Acerus’ shares trade on TSX under the symbol ASP. For more information, visit www.aceruspharma.com and follow us on Twitter and LinkedIn.

Contacts

Acerus Pharmaceuticals Corporation
Tricia Symmes, (416) 509-2116
Chief Operating Officer
tsymmes@aceruspharma.com

Contacts

Acerus Pharmaceuticals Corporation
Tricia Symmes, (416) 509-2116
Chief Operating Officer
tsymmes@aceruspharma.com